Nicolai Franzmeier
Overview
Explore the profile of Nicolai Franzmeier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheifele M, Gnorich J, Schroder E, Kunte S, Ells Z, Hagen J, et al.
Eur J Nucl Med Mol Imaging
. 2025 Mar;
PMID: 40064709
Purpose: Due to new advances in molecular and imaging biomarkers, a biological classification of Parkinson's disease (PD) called SyNeurGe (Hoglinger et al. Lancet Neurol 2024;23:191-204) has been proposed for research...
2.
Leuzy A, Bollack A, Pellegrino D, Teunissen C, La Joie R, Rabinovici G, et al.
Alzheimers Dement
. 2025 Mar;
21(3):e14528.
PMID: 40042435
Amyloid-β (Aβ) positron emission tomography (PET) imaging and cerebrospinal fluid (CSF) biomarkers are now established tools in the diagnostic workup of patients with Alzheimer's disease (AD), and their use is...
3.
Volter F, Eckenweber S, Scheifele M, Eckenweber F, Hirsch F, Franzmeier N, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 40019578
Purpose: Clinical staging in individuals with Alzheimer's disease (AD) typically relies on neuropsychological testing. Recognizing the imperative for an objective measure of clinical AD staging, regional perfusion in early-phase β-amyloid-PET...
4.
de Bruin H, Groot C, Kamps S, Vijverberg E, Steward A, Dehsarvi A, et al.
Brain Commun
. 2025 Jan;
7(1):fcaf009.
PMID: 39845735
Traumatic brain injury is widely viewed as a risk factor for dementia, but the biological mechanisms underlying this association are still unclear. In previous studies, traumatic brain injury has been...
5.
Roemer-Cassiano S, Wagner F, Evangelista L, Rauchmann B, Dehsarvi A, Steward A, et al.
Sci Transl Med
. 2025 Jan;
17(782):eadp2564.
PMID: 39841807
In Alzheimer's disease (AD), amyloid-β (Aβ) triggers the aggregation and spreading of tau pathology, which drives neurodegeneration and cognitive decline. However, the pathophysiological link between Aβ and tau remains unclear,...
6.
Wagemann O, Brendel M, Franzmeier N, Nubling G, Gnorich J, Zaganjori M, et al.
Front Neurosci
. 2025 Jan;
18():1505999.
PMID: 39834700
Purpose Of The Report: Adults with Down Syndrome (DS) have a substantially increased risk for Alzheimer's disease (AD) due to the triplicated amyloid-precursor-protein gene on chromosome 21, resulting in amyloid...
7.
Bauer T, Brendel M, Zaganjori M, Bernhardt A, Bernhardt A, Jack A, et al.
Neuroimage
. 2025 Jan;
306():121001.
PMID: 39798829
Aim: Standardized evaluation of [F]PI-2620 tau-PET scans in 4R-tauopathies represents an unmet need in clinical practice. This study aims to investigate the effectiveness of visual evaluation of [F]PI-2620 images for...
8.
Quattrone A, Franzmeier N, Levin J, Petzold G, Spottke A, Brosseron F, et al.
Mov Disord
. 2025 Jan;
PMID: 39797511
Background: The recent Movement Disorders Society (MDS)-progressive supranuclear palsy (PSP) diagnostic criteria conceptualized three clinical diagnostic certainty levels: "suggestive of PSP" for sensitive early diagnosis based on subtle clinical signs,...
9.
Biel D, Suarez-Calvet M, Dewenter A, Steward A, Roemer S, Dehsarvi A, et al.
EMBO Mol Med
. 2025 Jan;
17(2):235-248.
PMID: 39794447
In Alzheimer's disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we...
10.
Perellon-Alfonso R, Abellaneda-Perez K, Pileckyte I, Cabello-Toscano M, Mulet-Pons L, Vaque-Alcazar L, et al.
Heliyon
. 2025 Jan;
10(24):e41118.
PMID: 39759333
In early-stage Alzheimer's disease (AD) amyloid-β (Aβ) deposition can induce neuronal hyperactivity, thereby potentially triggering activity-dependent neuronal secretion of phosphorylated tau (p-tau), ensuing tau aggregation and spread. Therefore, cortical excitability...